Schedule 13G ownership disclosure

Replimune Group Inc

Common Stock · CUSIP: 76029N106

Event date: 2024-12-31

Filing-level shares
3,595,848
Percent of class
4.77%
  • The Vanguard Group

    Shares: 3,595,848 · Class: 4.77%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000229
Form type
SCHEDULE 13G/A
Filer
Replimune Group, Inc.
CIK
CIK 1737953
Filed
Jan 31, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub